Good quality white‐light transurethral resection of bladder tumours (GQ‐WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non‐muscle‐invasive bladder cancer: validation across time and place and recommendation for benchmarking

Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experie...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 109; no. 11; pp. 1666 - 1673
Main Authors Mariappan, Paramananthan, Finney, Steven M., Head, Elizabeth, Somani, Bhaskar K., Zachou, Alexandra, Smith, Gordon, Mishriki, Said F., N'Dow, James, Grigor, Kenneth M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2012
Wiley-Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1464-4096
1464-410X
1464-410X
DOI10.1111/j.1464-410X.2011.10571.x

Cover

Abstract Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. OBJECTIVE •  To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. PATIENTS AND METHODS •  Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. •  Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re‐TURBT were evaluated. •  Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). •  Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re‐TURBT or the first check cystoscopy. RESULTS •  From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. •  Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7–7.5, P < 0.001). •  Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3–10.7, P < 0.001) •  Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1–12.9, P < 0.001). CONCLUSIONS •  Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. •  Documented complete resection by experienced surgeons with DM presence (good quality white‐light TURBT) should be considered a benchmark for white‐light TURBT in NMIBC.
AbstractList Study Type - Therapy (cohort) Level of Evidence2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. OBJECTIVE * To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. PATIENTS AND METHODS * Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. * Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. * Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). * Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy. RESULTS * From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. * Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). * Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) * Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001). CONCLUSIONS * Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. * Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC. [PUBLICATION ABSTRACT]
Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours.UNLABELLEDStudy Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours.To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT.OBJECTIVETo validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT.Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK.   Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy.PATIENTS AND METHODSPatients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK.   Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy.From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001).RESULTSFrom a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001).Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. •  Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC.CONCLUSIONSDetrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. •  Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC.
Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK.   Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy. From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001). Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. •  Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC.
Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours. OBJECTIVE •  To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. PATIENTS AND METHODS •  Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK. •  Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re‐TURBT were evaluated. •  Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). •  Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re‐TURBT or the first check cystoscopy. RESULTS •  From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. •  Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7–7.5, P < 0.001). •  Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3–10.7, P < 0.001) •  Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1–12.9, P < 0.001). CONCLUSIONS •  Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. •  Documented complete resection by experienced surgeons with DM presence (good quality white‐light TURBT) should be considered a benchmark for white‐light TURBT in NMIBC.
Author Mariappan, Paramananthan
Finney, Steven M.
Zachou, Alexandra
N'Dow, James
Smith, Gordon
Grigor, Kenneth M.
Somani, Bhaskar K.
Head, Elizabeth
Mishriki, Said F.
Author_xml – sequence: 1
  givenname: Paramananthan
  surname: Mariappan
  fullname: Mariappan, Paramananthan
– sequence: 2
  givenname: Steven M.
  surname: Finney
  fullname: Finney, Steven M.
– sequence: 3
  givenname: Elizabeth
  surname: Head
  fullname: Head, Elizabeth
– sequence: 4
  givenname: Bhaskar K.
  surname: Somani
  fullname: Somani, Bhaskar K.
– sequence: 5
  givenname: Alexandra
  surname: Zachou
  fullname: Zachou, Alexandra
– sequence: 6
  givenname: Gordon
  surname: Smith
  fullname: Smith, Gordon
– sequence: 7
  givenname: Said F.
  surname: Mishriki
  fullname: Mishriki, Said F.
– sequence: 8
  givenname: James
  surname: N'Dow
  fullname: N'Dow, James
– sequence: 9
  givenname: Kenneth M.
  surname: Grigor
  fullname: Grigor, Kenneth M.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25918765$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22044434$$D View this record in MEDLINE/PubMed
BookMark eNqVkt1u0zAUxwMaYh_wCsgSQhoXLXHipOkukNgEA1QJgVrBneXaJ62LY3e2s7Z3PALPyJNw0nadtCvITU6c3_mfD_9PkyPrLCQJoWmf4vNm0aesZD1G0x_9LKW0T9NiQPvrx8nJ4cfRXZwOy-PkNIRFmuJBWTxNjrMsZYzl7ORRde2cIjetMDpuyGquI_z59dvo2TyS6IUNrYc498IQDwFk1M4SV5OpEUqBJ7FtXOsDOb_-imnfR-PJt8vxa7LScU5gvQSvwUpQBGVm4GwgeFQ732g7I9I1SwMR7pUDEVYRN41C245QEH0bnCdNG6TpQNVKCASENxv8kq33nT7RllhYEdwSdrGDMdD2VgR9C4dupUDYX5BbnFaJ7SxCehcCibqBbfGlEXIXobxrGrB7ELsmUyw2b4T_ic09S57UwgR4vn-fJZMP78dXH3ujL9efrt6NepINKtoDNRwMqFSFzFMoqKBVwXKoM6UEUzIrK8EqKEVN2RDyAagMplVWM0XrXKZTIfOz5Hynu_TupoUQeaODBGOEBdcGTvH6qyJlGUP05QN0gZdjsTtO8yLP2bDMM6Re7Kl22oDiS69xpA2_8wQCr_aACFKYGl0gdbjniiGtBmWBXLXjtiv0UB8QmvLOpnzBOwfyzo28synf2pSvMfXtg1Sp43bP6Dlt_kNgpQ1s_rkwv_w82Yb5X94mDqY
CODEN BJINFO
CitedBy_id crossref_primary_10_3389_fonc_2022_788568
crossref_primary_10_1016_j_jsurg_2018_08_001
crossref_primary_10_1097_j_pbj_0000000000000179
crossref_primary_10_1111_iju_15480
crossref_primary_10_1177_2051415819890464
crossref_primary_10_1089_end_2015_0591
crossref_primary_10_3310_PLPU1526
crossref_primary_10_1007_s00092_016_0917_0
crossref_primary_10_1186_s13063_017_1843_5
crossref_primary_10_1016_j_eururo_2016_03_053
crossref_primary_10_1097_MOU_0000000000000751
crossref_primary_10_1016_j_ejso_2018_06_004
crossref_primary_10_4111_icu_2016_57_S1_S44
crossref_primary_10_1080_21681805_2019_1604568
crossref_primary_10_1007_s13193_022_01516_8
crossref_primary_10_3390_cancers12103063
crossref_primary_10_1016_j_euf_2023_07_002
crossref_primary_10_4111_kju_2015_56_8_553
crossref_primary_10_1016_j_urology_2015_04_015
crossref_primary_10_4111_kju_2015_56_11_749
crossref_primary_10_1002_cncr_29071
crossref_primary_10_1111_bju_12355
crossref_primary_10_1111_bju_12235
crossref_primary_10_3109_21681805_2014_1000963
crossref_primary_10_1111_bju_16433
crossref_primary_10_1016_j_juro_2016_03_151
crossref_primary_10_1111_j_1464_410X_2012_11011_4_x
crossref_primary_10_1016_j_euo_2024_01_012
crossref_primary_10_1159_000528926
crossref_primary_10_1016_j_juro_2014_01_087
crossref_primary_10_1517_14712598_2013_824421
crossref_primary_10_2196_42254
crossref_primary_10_1016_j_eucr_2015_10_006
crossref_primary_10_1016_j_juro_2014_02_2573
crossref_primary_10_3390_cancers16193361
crossref_primary_10_48095_cccu2018034
crossref_primary_10_1097_MOU_0000000000000281
crossref_primary_10_1007_s00345_024_05342_1
crossref_primary_10_1186_s12894_023_01278_7
crossref_primary_10_4103_UROS_UROS_133_22
crossref_primary_10_1016_j_urolonc_2014_04_005
crossref_primary_10_1038_s41379_019_0403_9
crossref_primary_10_36290_uro_2017_004
crossref_primary_10_1016_j_euf_2021_07_011
crossref_primary_10_3109_21681805_2016_1163616
crossref_primary_10_1007_s11934_016_0579_1
crossref_primary_10_1097_PAP_0000000000000152
crossref_primary_10_3233_BLC_160076
crossref_primary_10_1016_j_urolonc_2023_08_004
crossref_primary_10_3390_cancers16101936
crossref_primary_10_1007_s11934_014_0450_1
crossref_primary_10_1016_j_eururo_2020_06_051
crossref_primary_10_1111_bju_15150
crossref_primary_10_1007_s00345_017_2077_6
crossref_primary_10_1016_j_acuro_2023_10_007
crossref_primary_10_3238_arztebl_m2021_0013
crossref_primary_10_1080_21681805_2022_2041086
crossref_primary_10_1586_era_12_87
crossref_primary_10_1080_21681805_2022_2119271
crossref_primary_10_1007_s00345_012_0967_1
crossref_primary_10_1038_s41585_024_00904_9
crossref_primary_10_1007_s00345_019_02734_6
crossref_primary_10_1002_bco2_365
crossref_primary_10_1016_j_eururo_2016_05_041
crossref_primary_10_1089_end_2015_1507
crossref_primary_10_1111_iju_14761
crossref_primary_10_1007_s00345_018_2602_2
crossref_primary_10_1016_j_juro_2017_04_077
crossref_primary_10_1016_j_eururo_2018_02_014
crossref_primary_10_1016_j_aju_2016_10_003
crossref_primary_10_1080_14737140_2018_1535314
crossref_primary_10_1016_j_acuroe_2023_12_007
crossref_primary_10_1016_j_eururo_2014_01_006
crossref_primary_10_1007_s00345_013_1035_1
crossref_primary_10_1007_s11934_024_01243_3
crossref_primary_10_1016_j_euf_2020_08_007
crossref_primary_10_1111_j_1464_410X_2012_11011_3_x
crossref_primary_10_2147_RRU_S386026
crossref_primary_10_3390_life12050641
crossref_primary_10_1007_s13629_014_0110_8
crossref_primary_10_1016_j_eururo_2013_06_003
crossref_primary_10_1016_j_jfma_2021_01_012
crossref_primary_10_1016_j_urolonc_2021_05_036
crossref_primary_10_1111_ijcp_12075
crossref_primary_10_1177_0391560319899303
crossref_primary_10_1089_end_2020_0821
Cites_doi 10.1097/01.ju.0000070437.14275.e0
10.1016/j.urology.2009.08.082
10.1016/j.urology.2005.08.066
10.1016/S1569-9056(08)60267-5
10.1097/01.ju.0000181811.61199.35
10.1016/j.eursup.2009.06.003
10.1016/S0022-5347(05)64273-5
10.1097/00005392-199907000-00018
10.1016/j.ucl.2005.02.002
10.1016/S0022-5347(05)64993-2
10.1016/S0022-5347(05)66532-9
10.1111/j.1464-410X.2006.06145.x
10.1016/S0302-2838(02)00068-4
10.1097/01.ju.0000158450.71497.ae
10.1016/S0022-5347(05)65969-1
10.1016/S0302-2838(01)00026-4
10.1016/S0090-4295(02)01920-9
10.1016/j.juro.2006.10.048
10.1016/S1569-9056(08)60433-9
10.1016/j.eururo.2009.05.047
10.1111/j.1464-410X.2008.07966.x
10.1097/01.ju.0000149163.08521.69
10.1097/01.ju.0000125486.92260.b2
ContentType Journal Article
Contributor Bollina, Prasad
McNeill, Alan
Donat, Roland
Riddick, Anthony
Contributor_xml – sequence: 1
  givenname: Prasad
  surname: Bollina
  fullname: Bollina, Prasad
– sequence: 2
  givenname: Alan
  surname: McNeill
  fullname: McNeill, Alan
– sequence: 3
  givenname: Roland
  surname: Donat
  fullname: Donat, Roland
– sequence: 4
  givenname: Anthony
  surname: Riddick
  fullname: Riddick, Anthony
Copyright 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
2015 INIST-CNRS
2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
Copyright_xml – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
– notice: 2015 INIST-CNRS
– notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
CorporateAuthor for members of the Edinburgh Urological Cancer Group
Edinburgh Urological Cancer Group
CorporateAuthor_xml – name: for members of the Edinburgh Urological Cancer Group
– name: Edinburgh Urological Cancer Group
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
DOI 10.1111/j.1464-410X.2011.10571.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 1673
ExternalDocumentID 2975457011
22044434
25918765
10_1111_j_1464_410X_2011_10571_x
BJU10571
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
23N
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
ID FETCH-LOGICAL-c4781-ed9771cd5c30e51a18543ef2dda4dc268a48e6af149e37ed2eb82f4d1f3c0bac3
IEDL.DBID DR2
ISSN 1464-4096
1464-410X
IngestDate Thu Sep 04 19:43:04 EDT 2025
Fri Jul 25 04:14:41 EDT 2025
Mon Jul 21 06:04:48 EDT 2025
Mon Jul 21 09:13:21 EDT 2025
Thu Apr 24 23:13:11 EDT 2025
Tue Jul 01 03:49:54 EDT 2025
Sun Sep 21 06:23:46 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Nephrology
Relapse
White light
transurethral resection of bladder tumour
Complete
Time
Transurethral route
Urology
Surgery
Detrusor muscle
Quality
Validation
Urinary system disease
Surgical resection
Urinary tract disease
Malignant tumor
Bladder cancer
Bladder tumor
Surgeon
Recommendation
recurrence
Treatment
Quality control
Early
Surgical approach
Bladder disease
Non muscle invasive bladder cancer
Cancer
Language English
License CC BY 4.0
2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4781-ed9771cd5c30e51a18543ef2dda4dc268a48e6af149e37ed2eb82f4d1f3c0bac3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1464-410X.2011.10571.x
PMID 22044434
PQID 1353349632
PQPubID 1026371
PageCount 8
ParticipantIDs proquest_miscellaneous_1011850424
proquest_journals_1353349632
pubmed_primary_22044434
pascalfrancis_primary_25918765
crossref_primary_10_1111_j_1464_410X_2011_10571_x
crossref_citationtrail_10_1111_j_1464_410X_2011_10571_x
wiley_primary_10_1111_j_1464_410X_2011_10571_x_BJU10571
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2012
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: June 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
– name: Edgecliff
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley-Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley-Blackwell
– name: Wiley Subscription Services, Inc
References 2001; 166
2001; 165
2009; 57
2010; 75
2005; 173
2005; 174
2002; 41
1991; 67
2010; 108
2002; 168
2007; 177
2004; 171
2002; 167
2005; 97
1999; 162
2008; 7
2009; 8
2003; 170
2005; 32
2002; 60
2008; 102
2005; 66
e_1_2_8_23_2
e_1_2_8_24_2
e_1_2_8_25_2
e_1_2_8_26_2
e_1_2_8_9_2
e_1_2_8_2_2
e_1_2_8_4_2
e_1_2_8_3_2
e_1_2_8_6_2
e_1_2_8_5_2
e_1_2_8_8_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_21_2
e_1_2_8_22_2
Anderson CH (e_1_2_8_27_2) 2010; 108
e_1_2_8_16_2
e_1_2_8_17_2
e_1_2_8_18_2
e_1_2_8_12_2
e_1_2_8_13_2
e_1_2_8_14_2
e_1_2_8_15_2
Koloszy Z (e_1_2_8_19_2) 1991; 67
e_1_2_8_10_2
e_1_2_8_11_2
22455408 - BJU Int. 2012 Apr;109(8):E27; author reply E27-8
References_xml – volume: 168
  start-page: 1964
  year: 2002
  end-page: 70
  article-title: Intravesical bacillus Calmette‐Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta‐analysis of the published results of randomized clinical trials
  publication-title: J Urol
– volume: 108
  start-page: 6
  issue: 1
  year: 2010
  article-title: RRFFC following PDD‐TURBT is better than even GQ‐WLTURBT – a prospective controlled study
  publication-title: BJU Int
– volume: 173
  start-page: 1108
  year: 2005
  end-page: 11
  article-title: A surveillance schedule in G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years: based on a 25‐year prospective database
  publication-title: J Urol
– volume: 41
  start-page: 523
  year: 2002
  end-page: 31
  article-title: Variability in the recurrence rate at first follow‐up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies
  publication-title: Eur Urol
– volume: 67
  start-page: 1761
  year: 1991
  end-page: 4
  article-title: Histopathological ‘self control’ in TUR of bladder tumours
  publication-title: Br J Urol
– volume: 7
  start-page: 269
  issue: 3
  year: 2008
  article-title: Completeness of the first resection of bladder tumour depending on the seniority of the surgeon
  publication-title: Eur Urol
– volume: 97
  start-page: 1194
  year: 2005
  end-page: 98
  article-title: A re‐staging transurethral resection predicts early progression of superficial bladder cancer
  publication-title: BJU Int
– volume: 165
  start-page: 808
  year: 2001
  end-page: 10
  article-title: Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early
  publication-title: J Urol
– volume: 8
  start-page: 542
  year: 2009
  end-page: 8
  article-title: Transurethral resection of non‐muscle invasive bladder cancer
  publication-title: Eur Urol Suppl
– volume: 57
  start-page: 843
  year: 2009
  end-page: 9
  article-title: Grigor KM and members of the Edinburgh Uro‐oncology group. Detrusor muscle in the first, apparently complete TURBT specimen is a surrogate marker of resection quality, predicts early recurrence and is dependent on operator experience
  publication-title: Eur Urol
– volume: 41
  start-page: 105
  year: 2002
  end-page: 12
  article-title: Guidelines on bladder cancer
  publication-title: Eur Urol
– volume: 166
  start-page: 490
  year: 2001
  end-page: 3
  article-title: Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy
  publication-title: J Urol
– volume: 171
  start-page: 2186
  year: 2004
  end-page: 90
  article-title: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials
  publication-title: J Urol
– volume: 174
  start-page: 2260
  year: 2005
  end-page: 3
  article-title: The actual incidence of bladder perforation following transurethral bladder surgery
  publication-title: J Urol
– volume: 102
  start-page: 1242
  year: 2008
  end-page: 6
  article-title: Quality control in transurethral resection of bladder tumours
  publication-title: BJU Int
– volume: 167
  start-page: 2404
  year: 2002
  end-page: 7
  article-title: Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling
  publication-title: J Urol
– volume: 162
  start-page: 74
  year: 1999
  end-page: 6
  article-title: The value of a second transurethral resection in evaluating patients with bladder tumours
  publication-title: J Urol
– volume: 7
  start-page: 437
  issue: 3
  year: 2008
  article-title: Dedicated teaching programs can improve the quality of TUR of non‐muscle invasive bladder tumour (NMIBT): experience of a single institution
  publication-title: Eur Urol
– volume: 170
  start-page: 433
  year: 2003
  end-page: 7
  article-title: Effect of routine repeat transurethral resection for superficial bladder cancer: a long‐term observational study
  publication-title: J Urol
– volume: 32
  start-page: 133
  year: 2005
  end-page: 45
  article-title: Optimal management of the T1G3 bladder cancer
  publication-title: Urol Clin North Am
– volume: 75
  start-page: 365
  year: 2010
  end-page: 8
  article-title: Complete Transurethral Resection of Bladder Tumour’: are the guidelines being followed
  publication-title: Urology
– volume: 60
  start-page: 822
  year: 2002
  end-page: 5
  article-title: Impact of a second transurethral resection on the staging of T1 bladder cancer
  publication-title: Urology
– volume: 66
  start-page: 108
  issue: 6A
  year: 2005
  end-page: 25
  article-title: Management of stage T1 tumours of the bladder: international consensus panel
  publication-title: Urology
– volume: 177
  start-page: 867
  year: 2007
  end-page: 75
  article-title: Pattern of recurrence changes in noninvasive bladder tumours observed during 2 decades
  publication-title: J Urol
– volume: 173
  start-page: 1908
  year: 2005
  end-page: 11
  article-title: Does the management of bladder perforation during transurethral resection of superficial bladder tumours predispose to extravesical tumour recurrence?
  publication-title: J Urol
– ident: e_1_2_8_2_2
– ident: e_1_2_8_7_2
  doi: 10.1097/01.ju.0000070437.14275.e0
– ident: e_1_2_8_18_2
  doi: 10.1016/j.urology.2009.08.082
– ident: e_1_2_8_22_2
  doi: 10.1016/j.urology.2005.08.066
– ident: e_1_2_8_20_2
  doi: 10.1016/S1569-9056(08)60267-5
– ident: e_1_2_8_24_2
  doi: 10.1097/01.ju.0000181811.61199.35
– ident: e_1_2_8_3_2
  doi: 10.1016/j.eursup.2009.06.003
– volume: 108
  start-page: 6
  issue: 1
  year: 2010
  ident: e_1_2_8_27_2
  article-title: RRFFC following PDD‐TURBT is better than even GQ‐WLTURBT – a prospective controlled study
  publication-title: BJU Int
– ident: e_1_2_8_12_2
  doi: 10.1016/S0022-5347(05)64273-5
– ident: e_1_2_8_13_2
  doi: 10.1097/00005392-199907000-00018
– ident: e_1_2_8_23_2
  doi: 10.1016/j.ucl.2005.02.002
– ident: e_1_2_8_14_2
  doi: 10.1016/S0022-5347(05)64993-2
– ident: e_1_2_8_8_2
  doi: 10.1016/S0022-5347(05)66532-9
– ident: e_1_2_8_6_2
  doi: 10.1111/j.1464-410X.2006.06145.x
– ident: e_1_2_8_4_2
  doi: 10.1016/S0302-2838(02)00068-4
– ident: e_1_2_8_25_2
  doi: 10.1097/01.ju.0000158450.71497.ae
– ident: e_1_2_8_16_2
  doi: 10.1016/S0022-5347(05)65969-1
– ident: e_1_2_8_26_2
  doi: 10.1016/S0302-2838(01)00026-4
– ident: e_1_2_8_15_2
  doi: 10.1016/S0090-4295(02)01920-9
– volume: 67
  start-page: 1761
  year: 1991
  ident: e_1_2_8_19_2
  article-title: Histopathological ‘self control’ in TUR of bladder tumours
  publication-title: Br J Urol
– ident: e_1_2_8_5_2
  doi: 10.1016/j.juro.2006.10.048
– ident: e_1_2_8_21_2
  doi: 10.1016/S1569-9056(08)60433-9
– ident: e_1_2_8_9_2
  doi: 10.1016/j.eururo.2009.05.047
– ident: e_1_2_8_17_2
  doi: 10.1111/j.1464-410X.2008.07966.x
– ident: e_1_2_8_10_2
  doi: 10.1097/01.ju.0000149163.08521.69
– ident: e_1_2_8_11_2
  doi: 10.1097/01.ju.0000125486.92260.b2
– reference: 22455408 - BJU Int. 2012 Apr;109(8):E27; author reply E27-8
SSID ssj0014665
Score 2.3616998
Snippet Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size,...
Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size,...
Study Type - Therapy (cohort) Level of Evidence2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size,...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1666
SubjectTerms Aged
Benchmarking
Biological and medical sciences
Bladder cancer
Clinical Competence
Cohort Studies
Cystectomy
Cystoscopy
detrusor muscle
Female
Humans
Light
Male
Medical sciences
Middle Aged
Multivariate analysis
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Nephrology. Urinary tract diseases
Predictive Value of Tests
quality control
recurrence
transurethral resection of bladder tumour
Tumors
Tumors of the urinary system
Urinary Bladder Neoplasms - pathology
Urinary Bladder Neoplasms - surgery
Urinary system involvement in other diseases. Miscellaneous
Urinary tract. Prostate gland
Title Good quality white‐light transurethral resection of bladder tumours (GQ‐WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non‐muscle‐invasive bladder cancer: validation across time and place and recommendation for benchmarking
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10571.x
https://www.ncbi.nlm.nih.gov/pubmed/22044434
https://www.proquest.com/docview/1353349632
https://www.proquest.com/docview/1011850424
Volume 109
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5QDwgJUd6klGqQOMDBUWyvY4cbBdqqokhUicjN2qcaNbaj2OF14ifwG_klzOw6rlL1UCFu63hnH87M7szuzDeMveQqSmKbCpTvUAYcLZRgZNM0GMRipEfaSO5yEZx8Gh5N-PE0mbb-TxQL4_EhugM3kgy3XpOAC1lfFnIe8HAw9UiclLE27JM-GcZDgtF_f9ohSWFVl1XSk6DavunUc2VDGzvVnYWo8aNZn-3iKnV0U7t129PBNjtfT8x7pZz3V43sq5-XMB__z8zvsbutFgtvPdvdZzdN-YDdOmnv6R_eyA6rSoMP2PwB3-iq4s-v33M6CICGdsfV0jRnS2yCop9caAVUFuSc1sElNKsCe6jh1eFnJPvycTw53R-_BjozBtNhM2uoKaYbxQYWPvwBt2FwPvJoCVy0XIMoNVSy8ckwQBsKNKmWUKxqHD1W1MjfNRjCesYn5SCrlIFZCWh0QFmVOApfGQuz8qsgn_9utIoEZ_kGUGZnPkMVCPeXQjMrjOvceb65Eh1AFIVpU1kBjhokdnZWCHdp8YhNDj6M3x0FbY6KQFGQbmA0KtCh0omKByYJBao_PDY20lpwraJhJnhmhsKiIWri1OjIyCyyXIc2VgMpVPyYbeE0zFMGVmR8ZAd6lKWSJ0pmqKxnmbEyHSrSknssXfNjrloAd8ojMs83DDmeE2PkxBi5Y4z8e4-FHeXCg5hcg2Zvg-U7QrSXQ9xCkx7bXctA3q57dU5ZVCgFQRz12IvuNa5YdA0lSlOtanIqxK9EV-499sTLzkXjEeEXxvgmdRJw7eHm-8cTV9z5Z8pn7Db-Hnk_wF22hbxonqPG2cg9t5b8BU6Rfa8
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5QkQAJ8SwQKGWQOMDBUWyvY4cbRbSlJJWoEpGbtS-rEbEdxQ6vEz-B38gvYWbXcZWqhwpx28g7611nZndm5_Ex9pKrIAqzWKB8-9LjaKF4gyyOvV4oBnqgjeQWi2B03D-c8KNpNG3ggCgXxtWHaC_cSDLsfk0CThfS56Wce9zvTV0pToKs9buoUF6z7jrSkE7aWlLY1-JKOhpU3DfDei4caeOsurUQFX62zOFdXKSQbuq39oDav8Pm66W5uJQv3VUtu-rnuaqP_2ntd9ntRpGFt47z7rGrprjPro8aV_2DK8lBWWpwOZs_4Bt5K_78-j2nuwCo6YBcLU19usQhKAHKZldAmYGc01a4hHqV4xsqeHXwCck-D8eTk73xa6BrYzBteWYNFaV1o-TAwmVA4EkMNkwejYGzkSsQhYZS1g4PA7ShXJNyCfmqwtljR40sXoGhcs_4S9mqVcrArAC0O6AoC5yF64yNWfFVUNh_O1tFsrN8Ayi2MwdSBcL-p1DPcmNfboPfbIvuIPLcNGhWgLMGiS87zYX1W2yzyf778btDr4Gp8BTl6XpGow7tKx2psGciX6AGxEOTBVoLrlXQTwRPTF9kaIuaMDY6MDIJMq79LFQ9KVT4kG3hMsxjBplI-CDr6UESSx4pmaC-niQmk3FfkaLcYfGaIVPV1HAnKJF5umHL8ZQYIyXGSC1jpN87zG8pF66OySVodjd4viVEk9nHUzTqsJ21EKTN1lelBKRCKARh0GEv2se4aZEnShSmXFUUV4hfibzuHfbICc_Z4AGVMAzxSWxF4NLTTfeOJrb55J8pn7Mbh-PRMB1-OP74lN3EPoELC9xhW8iX5hkqoLXctRvLX-Qrgc0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5QkSokxPsRKGWQOMDBUWyvY4cbBdJS2gqqRORmrfehRo3tKHZ4nfgJ_EZ-CTO7jqtUPVSI20beWe86Mzvf7M6DsRdcBlFoYoHy7WceRwvFG5g49nqhGKiB0hm3tQgOj_p7Y74_iSaN_xPFwrj8EO2BG0mG3a9JwOfKnBdy7nG_N3GZOKlird9FPHmN91FrEkA6blNJYV9bVtLRIG5f9-q5cKQ1VXVjLir8asaVu7gIj67DW6ufhrfY6Wplzi3ltLuss678eS7p4_9Z-m12s4Gx8Mbx3R12VRd32eZhc1F_70qyW5YKXMTmD_hGdxV_fv2e0UkA1KQelwtdnyxwCAp_srEVUBrIZrQRLqBe5viGCl7ufkayLwej8fHO6BXQoTHoNjmzgoqCulFuYO7iH1APg3WSR1PgbOQKRKGgzGpXDQOUpkiTcgH5ssLZY0eFDF6BpmTP-EvanFVSw7QAtDqgKAucheuMjWnxVZDTfztbSZKzeA0otFNXogqE_Uuhnubavty6vtkWnUDkuW5qWQHOGjJ82Uku7K3FfTYevh-93fOaIhWepChdTytE0L5UkQx7OvIF4h8eahMoJbiSQT8RPNF9YdAS1WGsVaCzJDBc-SaUvUzI8AHbwGXoRwyMSPjA9NQgiTMeySxBtJ4k2mRxXxJM7rB4xY-pbDK4UyGRWbpmyfGUGCMlxkgtY6TfO8xvKecui8klaLbXWL4lRIPZRx0addjWSgbSZuOrUiqjQjUIwqDDnrePccuieyhR6HJZkVchfiW6c--wh052zgYPKIFhiE9iKwGXnm66sz-2zcf_TPmMbX56N0wPPhx9fMKuY5fA-QRusQ1kS_0U0Wedbdtt5S8DOoB8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Good+quality+white-light+transurethral+resection+of+bladder+tumours+%28GQ-WLTURBT%29+with+experienced+surgeons+performing+complete+resections+and+obtaining+detrusor+muscle+reduces+early+recurrence+in+new+non-muscle-invasive+bladder+cancer%3A+validation+across+time+and+place+and+recommendation+for+benchmarking&rft.jtitle=BJU+international&rft.au=Mariappan%2C+Paramananthan&rft.au=Finney%2C+Steven+M&rft.au=Head%2C+Elizabeth&rft.au=Somani%2C+Bhaskar+K&rft.date=2012-06-01&rft.eissn=1464-410X&rft.volume=109&rft.issue=11&rft.spage=1666&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10571.x&rft_id=info%3Apmid%2F22044434&rft.externalDocID=22044434
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon